Bellevue Life Sciences Acquisition Corp. Share Price Nasdaq
Equities
BLACU
US0791742077
Investment Holding Companies
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.86 USD | -.--% |
|
-.--% | +2.36% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 95.08M 7.51B |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 * | - |
Net Debt 2022 | 1.09M 86.24M | Net Debt 2023 | 56.58K 4.47M | EV / Sales 2023 | - |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
210
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 48.02% |
1 month | -1.63% | ||
3 months | -3.77% | ||
6 months | +2.36% | ||
Current year | +2.36% |
![Extreme 10.86](/images/extremecours_fleche.png)
![Extreme 10.65](/images/extremecours_fleche.png)
![Extreme 10.085](/images/extremecours_fleche.png)
![Extreme 10.085](/images/extremecours_fleche.png)
![Extreme 10.085](/images/extremecours_fleche.png)
![Extreme 10.085](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 29/02/20 |
Jin Yoo
DFI | Director of Finance/CFO | 50 | 31/08/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Guk-Hyun Hwang
CEO | Chief Executive Officer | 48 | 29/02/20 |
Jun Chul Whang
BRD | Director/Board Member | 59 | 31/07/20 |
Jin Park
BRD | Director/Board Member | 56 | 13/02/23 |
1st Jan change | Capi. | |
---|---|---|
+87.14% | 5.79B | |
+98.02% | 1.25B | |
+2.57% | 986M | |
+32.87% | 869M | |
+2.20% | 667M | |
+0.54% | 653M | |
-.--% | 600M | |
+10.28% | 536M | |
-.--% | 500M |
- Stock Market
- Equities
- BLAC Stock
- BLACU Stock